Hepatitis C virus, autoimmunity and lymphoproliferation

Area of Science:

• Hepatology
• Rheumatology
• Oncology

Background:

• Hepatitis C virus (HCV) infection is a global health concern affecting 1% of the world's population.
• Extrahepatic manifestations of HCV are diverse, encompassing autoimmune, rheumatic, and lymphoproliferative disorders.
• The pathogenesis linking HCV to these conditions, including non-Hodgkin's lymphoma, requires further elucidation.

Observation:

• A patient presented with cryoglobulinemic leg ulcers, sensorimotor neuropathy, and pulmonary infiltrates, indicative of extrahepatic HCV disease.
• The patient also exhibited B-cell lymphoproliferation, diagnosed as extranodal lymphoma, and a Type II IgM monoclonal rheumatoid factor.
• Despite treatments including corticosteroids and interferon, symptoms were only partially responsive, and the patient succumbed to sepsis.

Findings:

• Chronic hepatitis was mild, but fibrotic changes progressed over three years.
• Liver function tests remained normal except for transient changes during interferon treatment.
• The case underscores the complex interplay between HCV infection and its varied systemic complications.

Implications:

• The study highlights the significant public health challenge posed by chronic HCV infection and its extrahepatic sequelae.
• Current therapies show limited efficacy in achieving sustained viral clearance, necessitating the development of novel treatment strategies.
• Investigating the link between HCV and non-Hodgkin's lymphoma may offer insights into viral oncogenesis.